Intrastriatal serotonin 5‐HT2 receptors mediate dopamine D1‐induced hyperlocomotion in 6‐hydroxydopamine‐lesioned rats
Authors:
Abstract
Striatal dopamine (DA) and serotonin (5‐HT) functions are altered following DA denervation. Previous research indicates that intrastriatal coadministration of D1 and 5‐HT2 receptor agonists synergistically increase locomotor behavior in DA‐depleted rats. In the present study, we examined whether striatal 5‐HT2 mechanisms also account for supersensitive D1‐mediated locomotor behavior following DA denervation. Adult male Sprague‐Dawley rats were subjected to bilateral striatal cannulation and then received either intracerebroventricular (i.c.v.) or intrastriatal 6‐hydroxydopamine (6‐OHDA; 200 μg or 20 μg/side, respectively). After at least 3 weeks, i.c.v.‐lesioned rats received intrastriatal infusions of the 5‐HT2 receptor antagonist ritanserin (2.0 μg/side) or its vehicle (DMSO) followed by systemic SKF 82958, a D1 agonist (1.0 mg/kg, i.p.) and locomotor activity was monitored. In another experiment, intrastriatal sham and 6‐OHDA‐lesioned rats received bilateral intrastriatal infusions of ritanserin (2.0 μg/side) or its vehicle (DMSO) followed by intrastriatal infusions of SKF 82958 (5.0 μg/side) or vehicle (0.9% saline). Rats with DA loss demonstrated supersensitive locomotor responses to both systemic and intrastriatal SKF 82958. Ritanserin pretreatment blunted systemic SKF 82958‐induced hyperlocomotion and returned intrastriatal D1‐mediated hyperactivity to sham lesion levels. The results of this study suggest that striatal 5‐HT2 receptors contribute to D1‐mediated hyperkinesias resulting from DA loss and suggest a pharmacological target for the alleviation of dyskinesia that can develop with continued DA replacement therapy. Synapse 50:164–170, 2003.Keywords
This publication has 40 references indexed in Scilit:
- Increased Dopamine Receptor Signaling and Dopamine Receptor-G Protein Coupling in Denervated StriatumThe Journal of Pharmacology and Experimental Therapeutics, 2002
- Serotonin 2A receptor mRNA levels in the neonatal dopamine-depleted rat striatum remain upregulated following suppression of serotonin hyperinnervationDevelopmental Brain Research, 1999
- Serotonin Enhances Striatal Dopamine Outflow In Vivo Through Dopamine Uptake SitesJournal of Neurochemistry, 1996
- 5-HT2 receptor subtypes: A family re-united?Trends in Pharmacological Sciences, 1995
- 6-Hydroxydopamine lesions of rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons.Proceedings of the National Academy of Sciences, 1994
- Suppression of dyskinesias in advanced Parkinson's disease: Moderate daily clozapine doses provide long‐term dyskinesia reductionMovement Disorders, 1994
- Chapter 6 Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor, “prefrontal” and “limbic” functions1991
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989
- Regulation of serotonin-stimulated phosphoinositide hydrolysis: relation to the serotonin 5-HT-2 binding siteJournal of Neuroscience, 1986
- Open Pilot Trial of Ritanserin in ParkinsonismClinical Neuropharmacology, 1986